Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The intestinal microbiome and host cell ecosystem refers to the vast and complex community of microorganisms—including bacteria, archaea, fungi, and viruses—that reside within the human gastrointestinal tract and interact intimately with host epithelial and immune cells (NIH, 2012). This ecosystem is fundamental to human physiology, contributing to the fermentation of non-digestible dietary fibers, the synthesis of vitamins K and B12, and the maturation of the mucosal immune system (Nature, 2020). A healthy, diverse microbiome maintains the integrity of the intestinal barrier and prevents the colonization of pathogens through niche competition. Dysregulation of this system, termed dysbiosis, is implicated in the pathogenesis of numerous local and systemic diseases, ranging from Crohn's disease to metabolic syndrome and colorectal cancer (Science, 2012). While not a single molecular target, the ecosystem is a major focus of therapeutic intervention; drugs can either directly target specific microbes (antibiotics), introduce beneficial species (probiotics), or be metabolized by the flora, which significantly alters drug efficacy and toxicity (PubMed, 2014).
Modulation of microbial composition and diversity, production of bioactive metabolites like short-chain fatty acids, competitive inhibition of pathogens, and regulation of host mucosal immunity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal microbiome and host cell ecosystem.